Get started
Live feed
·
SECFilingvia Quantisnow
Elicio Therapeutics Inc. logo

ELTX: Elicio Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ELTX

Across the 22 sessions after earlier ELTX headlines, the stock closed higher 13 times and lower 8 times, with a median move of 4.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ELTX close-to-close change in the session after earlier headlines
SessionEarlier headlineELTXSPY
Jun 18, 2026Ladenburg Thalmann resumed coverage on Elicio Therapeutics with a new price target-18.3%+0.8%
Jun 17, 2026Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer+70.7%-1.2%
Jun 15, 2026Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer-72.5%+1.8%
Jun 10, 2026B. Riley Securities initiated coverage on Elicio Therapeutics with a new price target+0.7%-1.6%
Jun 1, 2026Elicio Therapeutics Announces Publication in Peer-Reviewed Journal Science Advances Highlighting Potent and Durable Immune Responses Driven by Company's AMP-DNA Adjuvant Technology+5.9%+0.3%
May 12, 2026Elicio Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Updates-9.1%-0.2%
Quantisnow market dataNASDAQ
Elicio Therapeutics Inc. logo
ELTX
Elicio Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2021
Get push alerts for ELTX

Follow ELTX and get a push notification the moment its next story breaks.

Full ELTX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELTX (Elicio Therapeutics Inc.) and more on Quantisnow.